KRYS Krystal Biotech Inc

Krystal Biotech Inc is a biopharmaceutical company. It uses gene therapy treatments for patients suffering from rare debilitating disorders.

$64.86  -3.23 (-4.74%)
As of 06/28/2022 15:59:51 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/20/2017
Outstanding shares:  25,635,138
Average volume:  199,685
Market cap:   $1,756,519,656
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BD6JX35
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   3.15
PS ratio:   0.00
Return on equity:   -18.91%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy